Library

You have 0 saved results.
Mark results and click the "Add To Watchlist" link in order to add them to this list.
feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 263 (1969), S. 281-296 
    ISSN: 1432-1912
    Keywords: Enzyme Induction ; Drug Metabolism ; Microsomal Redox Enzymes ; Chlorinated Hydrocarbons ; Enzyminduktion ; Arzneimittel-Stoffwechsel ; Mikrosomale Redoxenzyme ; Chlorkohlenwasserstoffe
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Description / Table of Contents: Zusammenfassung Die Aktivität einiger Redoxenzyme der Rattenleber wurde nach Behandlung mit folgenden induzierenden Substanzen untersucht: Phenobarbital, α-Hexachlorcyclohexan (α-HCH), CFT 1201 (Phenyldiallylessigsäure-diäthylaminoäthylester) sowie 3,4-Benzpyren. Der zeitliche Ablauf der Aktivitätsänderungen wurde verfolgt. 1. α-HCH und CFT 1201 erhöhen ebenso wie Phenobarbital die Cytochrom-P450-Konzentration und die NADPH-abhängige Reduktion von Cytochrom c. Die Aktivität der NADH-Cytochrom c-Reduktase wird durch die drei Substanzen gesenkt. Die Aktivität der Aldehyd-Oxydase aus Hyaloplasma wird nur durch α-HCH beschleunigt. 2. Phenobarbital und α-HCH steigern die Demethylierungsrate von Aminopyrin wesentlich mehr als die Konzentration des Cytochroms P450. Benzpyren erhöht die Hydroxylierungsgeschwindigkeit von Acetanilid stärker als die Konzentration des P450. 3. CFT 1201 hemmt die Acetanilid-Oxydation nur in vivo, nicht aber in vitro. 4. Phenobarbital induziert die mikrosomalen Enzyme stärker als α-HCH, während dieses — wie frühere Befunde zeigten — zu einer stärkeren Proliferation der Leberzellen führt.
    Notes: Summary In rats, the activity of some hepatic redox-enzymes was measured following the administration of the enzyme-inducing substances phenobarbital, α-hexachlorocyclohexane (α-HCH = α-benzene hexachloride), CFT 1201 (phenyl-diallylacetic acid ester of diethylaminoethanol), or 3,4-benzpyrene. In particular, the time course of changes in enzyme activities was studied. 1. α-HCH and CFT 1201, like phenobarbital, increase the concentration of cytochrome P450 and accelerate the NADPH-dependent reduction of cytochrome c. All three substances reduce the activity of NADH-cytochrome c-reductase. On the other hand, only α-HCH, increases aldehyde oxidase activity in the hyaloplasm. 2. Phenobarbital and α-HCH both enhance the rate of demethylation of aminopyrine considerably more than they increase the concentration of cytochrome P450. Similarly, benzpyrene produces an increase in the rate of hydroxylation of acetanilide that is higher than the increase in concentration of P450. 3. CFT 1201 inhibits acetanilide-oxidation in vivo, but not in vitro. 4. Phenobarbital induces microsomal enzymes more strongly than does α-HCH, whereas this latter compound—as earlier observations have shown—stimulates liver cell proliferation much more than phenobarbital.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    Electronic Resource
    Electronic Resource
    Springer
    Naunyn-Schmiedeberg's archives of pharmacology 288 (1975), S. 57-64 
    ISSN: 1432-1912
    Keywords: α-Hexachlorocyclohexane ; Biodegradation ; Renal Excretion ; Intestinal Excretion
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Summary 1. Urine and stools were collected daily of 4 adult rats kept in single cages and injected once i.p. with α-hexachlorocyclohexane (α-HCH; dose per animal 126–150 μmoles), labelled uniformly with 14-C (10.8–14.0×106 dpm per animal). 2. In 4 weeks, 65% of the label was excreted through the kidneys and 16% by way of the intestine, with an estimated 8% being retained in depot fat. 3. GLC-analysis of the pooled urine showed it to contain very little unchanged drug, on average 0.05% of the dose. The time-course of the renal excretion of 14-C-labelled substance corresponded rather closely to the excretion of organically bound 36-Cl seen in earlier experiments with 36-Cl-labelled drug, indicating that the majority of urinary metabolites, presumably, still bear chlorine. 4. All or nearly all of the faecal 14-C was found by GLC to be accounted for by the stool's content of unchanged α-HCH. 5. Taken together, the results indicate a mean extent of α-HCH-degradation in the rat in the order of 80–85% of a dose. 6. Two rats were given 400 mg/kg of “cold” α-HCH by mouth 4 days before i.p. application of 14-C-labelled drug and were found to excrete more label through the kidneys in the first week than did the non-pretreated rats. This indicates that the drug stimulates its own degradation.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...